Prostate cancer metastatic castration-resistant

Clinical trials for Prostate cancer metastatic castration-resistant explained in plain language.

Never miss a new study

Get alerted when new Prostate cancer metastatic castration-resistant trials appear

Sign up with your email to follow new studies for Prostate cancer metastatic castration-resistant, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 2 Not yet finished but already full! 1

New hope for tough prostate cancer: targeted drug combo shows promise

Disease control Ongoing

This study tests two drugs—abiraterone and olaparib—alone or together in men with advanced prostate cancer that has spread and no longer responds to hormone therapy. Only men whose tumors have certain DNA repair defects (like BRCA or ATM mutations) are included. The goal is to se…

Matched conditions: PROSTATE CANCER METASTATIC CASTRATION-RESISTANT

Phase 2 • Sponsor: Northwestern University • Aim: Disease control

Last updated Jun 27, 2026 13:01 UTC

Prostate cancer metastatic castration-resistant

Get alerted when new Prostate cancer metastatic castration-resistant trials appear

New hope for tough prostate cancer: targeted drug combo shows promise